Orlistat Related Compound C
USP/1478833 - United States Pharmacopeia (USP) Reference Standard
Synonym: Triphenylphosphine oxide; Ph3PO; TPPO; Triphenyl phosphorus oxide; Triphenylphosphine monoxide
CAS Number: 791-28-6
Empirical Formula (Hill Notation): C18H15OP
Molecular Weight: 278.28
MDL Number: MFCD00002080
Linear Formula: (C6H5)3PO
Product Type: Chemical
| API family | orlistat |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | crystalline |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C18H15OP/c19-20(16-10- |
| InChI key | FIQMHBFVRAXMOP-UHFFFAOYSA |
| manufacturer/tradename | USP |
| mp | 150-157 °C (lit.) |
| SMILES string | O=P(c1ccccc1)(c2ccccc2)c3 |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Orlistat Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Latanoprost • Orlistat |
| General description: | Orlistat Related Compound C is a chemical impurity related to the active pharmaceutical ingredient Orlistat. It is a by-product that can be formed during the synthesis of Orlistat and is closely monitored in biologic formulations. The presence of this compound is typically controlled, as it may impact the safety, efficacy, and regulatory compliance of the final product. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of USP Biologics Program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 - H412 |
| Precautionary statements | P301 + P312 + P330 - P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 150-157 °C (lit.) |
| UNSPSC | 41116107 |